Verastem Inc
NASDAQ:VSTM
Verastem Inc
NASDAQ:VSTM
Price:
9.38 USD
1.74%
Market Closed
Updated:
Apr 27, 2024
Verastem Inc
Cash from Financing Activities
|
Verastem Inc
Cash from Financing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Verastem Inc
NASDAQ:VSTM
|
Cash from Financing Activities
$134.2m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
9%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Financing Activities
-$17.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-17%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Financing Activities
-$5.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
16%
|
CAGR 10-Years
-7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Financing Activities
$21B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Financing Activities
-$562.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-88%
|
CAGR 10-Years
N/A
|
See Also
What is Verastem Inc's Cash from Financing Activities?
Cash from Financing Activities
134.2m
USD
134.2m
USD
Based on the financial report for Dec 31, 2023, Verastem Inc's Cash from Financing Activities amounts to 134.2m USD.
What is Verastem Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
9%
9%
Over the last year, the Cash from Financing Activities growth was 159%. The average annual Cash from Financing Activities growth rates for Verastem Inc have been 24% over the past three years , -12% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
